Serology for Trachoma Surveillance after Cessation of Mass Drug Administration

PLoS Neglected Tropical Diseases

Volumn 9, Issue 2, 2015, Pages

  Martin, Diana L ^a   Bid, Rhiannon ^b   Sandi, Frank ^c,d   Goodhew, E Brook ^a   Massae, Patrick A ^e   Lasway, Augustin ^f   Philippin, Heiko ^b,e   Makupa, William ^e   Molina, Sandra ^b   Holland, Martin J ^b   Mabey, David C W ^b   Drakeley, Chris ^b   Lammie, Patrick J ^a   Solomon, Anthony W ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

^d UNIVERSITY OF DODOMA   (Tanzania)

^e KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^f Huruma Hospital   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; IMMUNOGLOBULIN G; ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CHLAMYDIA TRACHOMATIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; FEMALE; HEALTH CARE MANAGEMENT; HEALTH CARE SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PUBLIC HEALTH; SEROLOGY; SEROPREVALENCE; STATISTICAL ANALYSIS; TRACHOMA; VERY ELDERLY; ANTIBODY PRODUCTION; BLINDNESS; BLOOD; EPIDEMIOLOGICAL MONITORING; EPIDEMIOLOGY; IMMUNOLOGY; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; PREVALENCE; TANZANIA; TREATMENT WITHDRAWAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; AZITHROMYCIN; BLINDNESS; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; CROSS-SECTIONAL STUDIES; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; TANZANIA; TRACHOMA; WITHHOLDING TREATMENT; YOUNG ADULT;

EID: 84924078438     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003555     Document Type: Article

References (33)

1. Mariotti SP, Pascolini D, Rose-Nussbaumer J, Trachoma: global magnitude of a preventable cause of blindness. The British journal of ophthalmology 2009; 93(5): 563–8. doi: 10.1136/bjo.2008.148494 19098034
2. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR, A simple system for the assessment of trachoma and its complications. Bull World Health Organ 1987; 65(4): 477–83. 3500800
3. Munoz B, Stare D, Mkocha H, Gaydos C, Quinn T, West SK, Can clinical signs of trachoma be used after multiple rounds of mass antibiotic treatment to indicate infection? Invest Ophthalmol Vis Sci 2011; 52(12): 8806–10. doi: 10.1167/iovs.11-8074 22025578
4. Solomon AW ZM, Kuper H, Buchan JC, Mabey DCW, Foster A, Trachoma Control: A Guide for Program Managers. World Health Organization Geneva, 2006.
5. Burton MJ, Hu VH, Massae P, et al. What Is Causing Active Trachoma? The Role of Nonchlamydial Bacterial Pathogens in a Low Prevalence Setting. Investigative ophthalmology & visual science 2011; 52(8): 6012–7.
6. See CW, Alemayehu W, Melese M, et al. How reliable are tests for trachoma?—a latent class approach. Invest Ophthalmol Vis Sci 2011; 52(9): 6133–7. doi: 10.1167/iovs.11-7419 21685340
7. Bailey R, Duong T, Carpenter R, Whittle H, Mabey D, The duration of human ocular Chlamydia trachomatis infection is age dependent. Epidemiology and Infection 1999; 123: 479–86 10694161
8. Solomon AW, Peeling RW, Foster A, Mabey DCW, Diagnosis and Assessment of Trachoma. Clinical Microbiology Reviews 2004b; 17(4): 982–1011. 15489358
9. Wright HR, Taylor HR, Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us? The Lancet Infectious Diseases 2005; 5(5): 313–20. 15854887
10. Mabey DCW, Solomon AW, Foster A, Trachoma. The Lancet 2003; 362(9379): 223–9. 12885486
11. Goodhew EB, Priest JW, Moss DM, et al. CT694 and pgp3 as serological tools for monitoring trachoma programs. PLoS Negl Trop Dis 2012; 6(11): e1873. doi: 10.1371/journal.pntd.0001873 23133684
12. Solomon AW, Harding-Esch E, Alexander ND, et al. Two doses of azithromycin to eliminate trachoma in a Tanzanian community. N Engl J Med 2008; 358(17): 1870–1. doi: 10.1056/NEJMc0706263 18434662
13. Solomon AW, Holland MJ, Alexander ND, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004; 351(19): 1962–71. 15525721
14. Solomon AW, Holland MJ, Burton MJ, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003; 362(9379): 198–204. 12885481
15. Drakeley CJ, Corran PH, Coleman PG, et al. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A 2005; 102(14): 5108–13. 15792998
16. Diamant J, Benis R, Schachter J, et al. Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infection. Ophthalmic epidemiology 2001; 8(2–3): 109–17. 11922386
17. Dize L, West S, Quinn TC, Gaydos CA, Pooling ocular swab specimens from Tanzania for testing by Roche Amplicor and Aptima Combo 2 assays for the detection of Chlamydia trachomatis: accuracy and cost-savings. Diagnostic microbiology and infectious disease 2013; 77(4): 289–91. doi: 10.1016/j.diagmicrobio.2013.08.005 24079951
18. Dize L, West SK, Mkocha H, Quinn TC, Gaydos CA. Evaluation of pooled ocular and vaginal swabs by the Cepheid GeneXpert CT/NG assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae compared to the GenProbe Aptima Combo 2 Assay. Diagnostic microbiology and infectious disease 2014.
19. Burton MJ, Holland MJ, Makalo P, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 2005; 365(9467): 1321–8. 15823382
20. Keenan JD, Lakew T, Alemayehu W, et al. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. Am J Trop Med Hyg 2010; 82(3): 482–7. doi: 10.4269/ajtmh.2010.09-0315 20207878
21. Burton MJ, Holland MJ, Makalo P, et al. Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities. PLoS neglected tropical diseases 2010; 4(10): e835. doi: 10.1371/journal.pntd.0000835 20957147
22. Bird M, Dawson CR, Schachter JS, et al. Does the Diagnosis of Trachoma Adequately Identify Ocular Chlamydial Infection in Trachoma-Endemic Areas? Journal of Infectious Diseases 2003; 187(10): 1669–73. 12721948
23. Capriotti J, Pelletier J, Shah M, Caivano D, Ritterband D, Normal ocular flora in healthy eyes from a rural population in Sierra Leone. International Ophthalmology 2009; 29(2): 81–4. doi: 10.1007/s10792-008-9196-4 18297243
24. Knopf HL, Hierholzer JC, Clinical and immunologic responses in patients with viral keratoconjunctivitis. Am J Ophthalmol 1975; 80(4): 661–72. 170831
25. Solomon AW, Bowman RJ, Yorston D, et al. Operational evaluation of the use of photographs for grading active trachoma. Am J Trop Med Hyg 2006; 74(3): 505–8. 16525114
26. Goodhew EB, Morgan SM, Switzer AJ, et al. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration. BMC Infect Dis 2014; 14: 216. doi: 10.1186/1471-2334-14-216 24755001
27. Hobson D, Rees E, Maternal genital chlamydial infection as a cause of neonatal conjunctivitis. Postgrad Med J 1977; 53(624): 595–7. 593978
28. Honorio NA, Nogueira RM, Codeco CT, et al. Spatial evaluation and modeling of Dengue seroprevalence and vector density in Rio de Janeiro, Brazil. PLoS Negl Trop Dis 2009; 3(11): e545. doi: 10.1371/journal.pntd.0000545 19901983
29. Ostyn B, Gidwani K, Khanal B, et al. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis 2011; 5(10): e1284. doi: 10.1371/journal.pntd.0001284 21991397
30. Corran P, Coleman P, Riley E, Drakeley C, Serology: a robust indicator of malaria transmission intensity? Trends Parasitol 2007; 23(12): 575–82. 17988945
31. Cook J, Reid H, Iavro J, et al. Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J 2010; 9: 169. doi: 10.1186/1475-2875-9-169 20553604
32. Gass K, Beau de Rochars MV, Boakye D, et al. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis 2012; 6(1): e1479. doi: 10.1371/journal.pntd.0001479 22272369
33. Solomon AW, Engels D, Bailey RL, et al. A diagnostics platform for the integrated mapping, monitoring, and surveillance of neglected tropical diseases: rationale and target product profiles. PLoS Negl Trop Dis 2012; 6(7): e1746. doi: 10.1371/journal.pntd.0001746 22860146